Astrana Health (NASDAQ:ASTH) Shares Up 7. 9% - Still a Buy?
Astrana Health, Inc. (NASDAQ:ASTH-Get Free Report)'s stock price was up 7. 9% during mid-day trading on Friday . The stock traded as high as $40. 67 and last traded at $40. 7880. Approximately 282,394 shares. . .
Astrana Health, Inc. (NASDAQ:ASTH-Get Free Report)'s stock price was up 7. 9% during mid-day trading on Friday . The stock traded as high as $40. 67 and last traded at $40. 7880. Approximately 282,394 shares traded hands during trading, a decline of 49% from the average daily volume of 554,100 shares. The stock had previously closed at $37. 79. GetAstrana Healthalerts:Analyst Upgrades and DowngradesASTH has been the subject of several recent research reports. TD Cowen lifted their price target on Astrana Health from $45. 00 to $50. 00 and gave the company a "buy" rating in a research report on Tuesday, July 14th. Needham & Company LLC upped their price target on Astrana Health from $30. 00 to $41. 00 and gave the company a "buy" rating in a research report on Friday, May 8th. Robert W. Baird set a $45. 00 price target on shares of Astrana Health in a report on Friday, May 8th. Wall Street Zenraised shares of Astrana Health from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Finally,Weiss Ratingsupgraded shares of Astrana Health from a "hold (c-)" rating to a "hold (c)" rating in a research report on Monday, June 1st. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $49. 43. Get Our Latest Research Report on Astrana HealthAstrana Health Price PerformanceThe firm's 50-day moving average is $41. 29 and its 200-day moving average is $32. 77. The company has a market capitalization of $2. 26 billion, a PE ratio of 49. 63 and a beta of 0. 87. The company has a quick ratio of 1. 35, a current ratio of 1. 23 and a debt-to-equity ratio of 1. 05. Hedge Funds Weigh In On Astrana HealthSeveral institutional investors have recently modified their holdings of ASTH. Swiss National Bank raised its position in Astrana Health by 1. 2% in the 3rd quarter. Swiss National Bank now owns 86,944 shares of the company's stock worth $2,465,000 after purchasing an additional 1,000 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Astrana Health by 5. 2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company's stock valued at $799,000 after buying an additional 1,263 shares during the period. Deutsche Bank AG boosted its position in Astrana Health by 3. 9% during the fourth quarter. Deutsche Bank AG now owns 41,265 shares of the company's stock valued at $1,024,000 after buying an additional 1,550 shares during the period. Price T Rowe Associates Inc. MD grew its stake in shares of Astrana Health by 3. 8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 42,258 shares of the company's stock valued at $1,049,000 after buying an additional 1,562 shares during the last quarter. Finally, Strs Ohio bought a new position in shares of Astrana Health during the fourth quarter valued at about $40,000. 52. 77% of the stock is currently owned by institutional investors. About Astrana Health(Get Free Report)Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Recommended StoriesFive stocks we like better than Astrana HealthSony and TSMC’s $4. 7 Billion Venture Is About More Than Camera SensorsQuantum Leaps: Debt-Free as AI Storage Demand AcceleratesNVIDIA's $500 Billion GPU Financing Deal Fuels Path Toward $270Sandisk’s Margins Look Like Software. Can They Last?This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat. com. Continue following MarketBeatAdd MarketBeat as your preferred source on Google to see our latest stories in your feed. Should You Invest $1,000 in Astrana Health Right Now?Before you consider Astrana Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified thefive stocksthat top analysts are quietly whispering to their clients to buy now before the broader market catches on. . . and Astrana Health wasn't on the list. While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks HereMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely. Get This Free Report